Sharemaestro Newsreel

Cosmos Health | RW: Registration Withdrawal Request

This moomoo community post, created by user DrJaguar8, discusses Cosmos Health (COSM.US) in the context of a "Registration Withdrawal Request." The post is brief, acting as a prompt for discussion rather than an in-depth analysis. It includes a disclaimer stating that the content is …

COR|Cencora Inc|Price:305.030|Chg%:+4.450

Cencora Inc. (COR) shows stable fundamentals and high growth potential, with its valuation considered fairly valued within the Healthcare Equipment & Supplies industry. Institutional ownership is high, and analysts largely rate it as a "Buy" with a target price of $352.43. While its performance …

Cosmos Health Inc. SEC Filing (Jul 22, 2026)

Cosmos Health Inc. (COSM) has formally requested the withdrawal of its Registration Statement on Form S-3 (File No. 333-290420), originally filed on September 19, 2025, with the Securities and Exchange Commission. The Company states that the Registration Statement has not been declared effective and …

Cardinal Health puts $360 million toward two acquisitions that expand home care business

Cardinal Health is acquiring AdaptHealth's Diabetes Health business and Strive Medical for approximately $360 million in cash. These acquisitions will expand Cardinal Health's at-Home Solutions business into diabetes management and urology, building on its prior acquisition of Advanced Diabetes Supply. The company anticipates these …

Is Trending Stock McKesson Corporation (MCK) a Buy Now?

McKesson Corporation (MCK) is highlighted as a trending stock, attracting attention from Zacks.com visitors. The article analyzes its recent stock performance, earnings estimate revisions, revenue growth forecasts, and valuation, concluding with a Zacks Rank #2 (Buy) recommendation. This suggests that McKesson may outperform the …

McKesson raises quarterly dividend 15% to $0.94 per share

McKesson Corporation announced a 15% increase in its quarterly dividend, raising it from $0.82 to $0.94 per share of common stock. This marks the company's tenth consecutive year of dividend growth, with payment scheduled for October 1, 2026, to shareholders of record as of …

Labcorp Prepares to Report Q2 Earnings: What's in the Cards?

Labcorp (LH) is set to announce its second-quarter 2026 results on July 30, with expectations for revenue growth of 5.4% and EPS improvement of 10.1%. Several strategic initiatives, including expansions, new product launches, and technological advancements, are anticipated to drive positive performance in both …

Cardinal Health acquires two home-care businesses for $360M

Cardinal Health Inc. is expanding its home-based care division by acquiring two businesses for $360 million. These acquisitions aim to bolster the Dublin-based company's fast-growing sector providing medical supplies for home care. The move follows previous reports of Cardinal Health boosting profit forecasts and …

Henry Schein (HSIC) Could Be 3% Undervalued As Earnings Come Into Focus

Mckesson Corporation (MCK) News, Articles, Events & Latest Updates

McKesson Corporation (MCK) has been in the news with several recent developments, including a 15% increase in its quarterly dividend to $0.94 per share. The stock has also seen analysis regarding its potential as a strong growth and value stock, despite some recent market …

Cencora stock trades steadily as pharmaceuticals distributor highlights rising revenue and earnings

Cencora stock is trading steadily, reflecting the pharmaceutical distributor's growing revenue and adjusted earnings, as highlighted in its recent quarterly figures. Investors are closely monitoring the company's margins, cash generation, and strategic focus on specialty distribution and services, which offer higher profitability. Cencora positions …

Cencora, Inc. Stock 12‑Month Price Target Raised to $354.58, Implies 17% Upside

Cencora, Inc.'s average stock price target has been raised to $354.58, an increase from $352.5, according to 12 analysts. This new target suggests a potential 17% upside from its current closing price, with individual forecasts ranging from $310 to $412 per share. The consensus …

Cardinal Health to buy Strive Medical, AdaptHealth's diabetes health business for $360M

Cardinal Health is expanding its home care business with two tuck-in acquisitions: AdaptHealth Corp's diabetes health unit and medical supply provider Strive Medical, totaling $360 million. These deals aim to accelerate Cardinal Health's at-home solutions growth strategy, building on previous acquisitions in diabetes management …

Cardinal Health's latest deals won't move the needle overnight. They still matter.

Cardinal Health recently acquired AdaptHealth's diabetes health business and Strive Medical for a combined $360 million to boost its home care segment. These acquisitions, though small, align with Cardinal Health's strategy to invest in faster-growing, higher-margin businesses, complementing its legacy distribution operations and strengthening …

McKesson Corporation announces Quarterly dividend, payable on October 01, 2026

McKesson Corporation announced a quarterly dividend of $0.9400 per share, payable on October 1, 2026. The ex-date and record date for this dividend are both September 1, 2026. This announcement keeps investors informed about the company's dividend distribution schedule.

Cardinal inks 2 acquisitions in bid to expand at-home services

Cardinal Health has acquired Strive Medical and the diabetes health business of AdaptHealth for a combined $360 million to expand its growing at-home solutions unit. These acquisitions are expected to increase Cardinal's earnings within a year and build on previous investments in the home …

WST Likely to Beat Q2 Earnings Estimates: How to Play the Stock?

West Pharmaceutical Services (WST) is expected to surpass its Q2 2026 earnings estimates, driven by strong demand for high-value products, biologics, and GLP-1 related components. The company's Proprietary Products segment is anticipated to be a key growth driver, with operating profit expected to increase …

Cardinal Health makes acquisition duo worth $360m for home care business advance

Cardinal Health has acquired Strive Medical and AdaptHealth’s diabetes business for a combined $360 million to bolster its home care solutions. These acquisitions aim to expand Cardinal Health's reach in diabetes management and urology, building on previous investments in the at-home care sector. The …

COSM stock trades around recent lows as Cosmos Health focuses on integrating acquisitions and stabil

Cosmos Health Inc. (COSM) stock is trading around recent lows as the company shifts its focus to integrating past acquisitions, stabilizing operations, and repairing its balance sheet. The article highlights the importance of revenue traction, margin development, and balance-sheet flexibility for investors, moving away …

ETFs Investing in Cencora, Inc. Stocks

This article lists various Exchange Traded Funds (ETFs) that hold Cencora, Inc. (COR) stocks, providing detailed financial information for each. The data includes market value, weight of COR in the fund, issuer, management style, focus, expense ratio, assets under management (AUM), price, change percentage, …

Henry Schein to announce Q2 2026 results on August 4

Henry Schein, Inc. will release its second-quarter 2026 financial results before the stock market opens on Tuesday, August 4, 2026. A live webcast of its earnings conference call will be held on the same day at 8:00 a.m. Eastern time, featuring CEO Fred Lowery …

Black Talon Announces Collaboration with Henry Schein One to Bring Continuous Cyber Readiness to Dental Practices

Black Talon Security has partnered with Henry Schein One's TechCentral to offer its EAGLEi™ continuous threat exposure management platform to dental practices. This collaboration aims to provide advanced cybersecurity tailored for the dental industry, combining TechCentral's IT expertise with Black Talon's security solutions to …

BofA Securities Adjusts McKesson Price Target to $925 From $900

BofA Securities has raised its price target for McKesson (NYSE: MCK) to $925, up from the previous target of $900. This adjustment comes amidst other analyst actions on McKesson, with varying price target changes and maintained ratings. The article also provides a brief overview …

Survey: Hospital brand loyalty drives care access decisions

A new U.S. News & World Report survey indicates that hospital brand loyalty is a major factor in patients' healthcare decisions, showing a desire for comprehensive care within a single system. While most patients would prioritize their relationship with a provider over a hospital …

Press Release: Henry Schein to Webcast Second Quarter 2026 Conference Call on Tuesday, August 4, 2026, at 8:00 A.m. ET

Henry Schein (HSIC) is scheduled to webcast its Second Quarter 2026 Conference Call on Tuesday, August 4, 2026, at 8:00 A.M. ET. The article also includes information about Unity Software's Q4 financial results, reporting revenue of $609 million and a quarterly loss of 66 …

McKesson stock trades near record levels as earnings and buybacks support valuation

McKesson stock is trading near its record highs, propelled by strong fiscal year 2026 earnings growth and significant share repurchases. The healthcare distributor's valuation on the NYSE is further bolstered by its strategic focus on specialty and oncology offerings, as well as its robust …

Henry Schein stock trades steady as dental and medical distribution margins hold after recent earnings

Henry Schein stock remains stable reflecting consistent demand for dental and medical supplies. Recent quarterly results highlight resilient revenue growth and strong margin management across its key segments, including dental, medical, and animal health. The company's ability to achieve growth through both volume and …

Cardinal Health (CAH) Stock Draws Fresh Price Target Split After Analyst Revisions

Cencora stock trades near record levels as earnings and guidance underpin healthcare distribution growth

Cencora Inc. stock is trading near record levels, reflecting strong recent earnings and raised guidance in the healthcare distribution business. The company reported significant revenue growth and a 25% increase in adjusted EPS for Q2 2024, leading to an upward revision of its full-year …

Cardinal Health expands home care business with two tuck-in acquisitions

Cardinal Health announced two strategic tuck-in acquisitions to expand its at-Home Solutions business. The company will acquire AdaptHealth Corp.'s Diabetes Health business and Strive Medical, a multi-specialty supply provider focused on urology. These transactions, totaling approximately $360 million, aim to strengthen Cardinal Health's leadership …

CAH: Earnings Execution And Specialty Expansion Will Balance Premium Valuation Risks

Cardinal Health's fair value has been updated to $250.53, reflecting recent upward revisions in analysts' price targets due to updated earnings models and views on execution and profit potential. While some bullish analysts foresee higher EPS, bearish analysts express caution, leading to mixed price …

Cardinal Health (CAH) Registers a Bigger Fall Than the Market: Important Facts to Note

Cardinal Health (CAH) closed down -1.21%, underperforming the S&P 500, Dow, and Nasdaq in the latest trading session. Despite this recent dip, the company is projected to see significant growth in its upcoming earnings report, with an expected 16.35% increase in EPS and 9.06% …

Cardinal Health buys AdaptHealth's diabetes unit and Strive Medical for $360M to boost home care.

Cardinal Health has acquired AdaptHealth's Diabetes Health business and Strive Medical for approximately $360 million in cash. These acquisitions aim to expand Cardinal Health's at-Home Solutions, strengthening its capabilities in diabetes management and urology supplies, and further solidifying its leadership in home healthcare. The …

Cardinal Health to buy AdaptHealth diabetes unit, Strive Medical for $360 million

Cardinal Health has announced plans to acquire AdaptHealth's diabetes health business and Strive Medical for a total of $360 million. This strategic move aims to expand Cardinal Health's home care solutions and build upon its previous acquisition of Advanced Diabetes Supply. Analysts view these …

Park Dental Partners sets Q2FY26 earnings release date

Park Dental Partners, Inc. has announced that it will release its financial results for the second quarter of fiscal year 2026, ending June 30, 2026, after market close on August 12, 2026. The company will also host a conference call on August 13, 2026, …

AdaptHealth sells diabetes unit to Cardinal Health for $235M

AdaptHealth Corp. is selling its Diabetes Health business to Cardinal Health for $235 million in cash, signaling a strategic move to concentrate on its core sleep, respiratory, and home medical equipment operations. This divestiture is part of a multi-year effort to streamline its portfolio …